BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 20512113)

  • 1. A novel ATP-dependent conformation in p97 N-D1 fragment revealed by crystal structures of disease-related mutants.
    Tang WK; Li D; Li CC; Esser L; Dai R; Guo L; Xia D
    EMBO J; 2010 Jul; 29(13):2217-29. PubMed ID: 20512113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered intersubunit communication is the molecular basis for functional defects of pathogenic p97 mutants.
    Tang WK; Xia D
    J Biol Chem; 2013 Dec; 288(51):36624-35. PubMed ID: 24196964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the N-domain in the ATPase activity of the mammalian AAA ATPase p97/VCP.
    Niwa H; Ewens CA; Tsang C; Yeung HO; Zhang X; Freemont PS
    J Biol Chem; 2012 Mar; 287(11):8561-70. PubMed ID: 22270372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and functional deviations in disease-associated p97 mutants.
    Tang WK; Xia D
    J Struct Biol; 2012 Aug; 179(2):83-92. PubMed ID: 22579784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D1 ring is stable and nucleotide-independent, whereas D2 ring undergoes major conformational changes during the ATPase cycle of p97-VCP.
    Wang Q; Song C; Yang X; Li CC
    J Biol Chem; 2003 Aug; 278(35):32784-93. PubMed ID: 12807884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleocytoplasmic shuttling of valosin-containing protein (VCP/p97) regulated by its N domain and C-terminal region.
    Song C; Wang Q; Song C; Lockett SJ; Colburn NH; Li CC; Wang JM; Rogers TJ
    Biochim Biophys Acta; 2015 Jan; 1853(1):222-32. PubMed ID: 25447673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between the AAA
    Rao MV; Williams DR; Cocklin S; Loll PJ
    J Biol Chem; 2017 Nov; 292(45):18392-18407. PubMed ID: 28939772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATP-bound form of the D1 AAA domain inhibits an essential function of Cdc48p/p97.
    Esaki M; Ogura T
    Biochem Cell Biol; 2010 Feb; 88(1):109-17. PubMed ID: 20130684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleotide dependent motion and mechanism of action of p97/VCP.
    DeLaBarre B; Brunger AT
    J Mol Biol; 2005 Mar; 347(2):437-52. PubMed ID: 15740751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imbalances in p97 co-factor interactions in human proteinopathy.
    Fernández-Sáiz V; Buchberger A
    EMBO Rep; 2010 Jun; 11(6):479-85. PubMed ID: 20414249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p97 Disease Mutations Modulate Nucleotide-Induced Conformation to Alter Protein-Protein Interactions.
    Bulfer SL; Chou TF; Arkin MR
    ACS Chem Biol; 2016 Aug; 11(8):2112-6. PubMed ID: 27267671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary inclusion body myopathy-linked p97/VCP mutations in the NH2 domain and the D1 ring modulate p97/VCP ATPase activity and D2 ring conformation.
    Halawani D; LeBlanc AC; Rouiller I; Michnick SW; Servant MJ; Latterich M
    Mol Cell Biol; 2009 Aug; 29(16):4484-94. PubMed ID: 19506019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenic VCP/TER94 alleles are dominant actives and contribute to neurodegeneration by altering cellular ATP level in a Drosophila IBMPFD model.
    Chang YC; Hung WT; Chang YC; Chang HC; Wu CL; Chiang AS; Jackson GR; Sang TK
    PLoS Genet; 2011 Feb; 7(2):e1001288. PubMed ID: 21304887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A unique IBMPFD-related P97/VCP mutation with differential binding pattern and subcellular localization.
    Erzurumlu Y; Kose FA; Gozen O; Gozuacik D; Toth EA; Ballar P
    Int J Biochem Cell Biol; 2013 Apr; 45(4):773-82. PubMed ID: 23333620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved structures of full-length p97, an AAA ATPase: implications for mechanisms of nucleotide-dependent conformational change.
    Davies JM; Brunger AT; Weis WI
    Structure; 2008 May; 16(5):715-26. PubMed ID: 18462676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational changes of p97 during nucleotide hydrolysis determined by small-angle X-Ray scattering.
    Davies JM; Tsuruta H; May AP; Weis WI
    Structure; 2005 Feb; 13(2):183-95. PubMed ID: 15698563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification, crystallization and preliminary X-ray diffraction analysis of disease-related mutants of p97.
    Tang WK; Li D; Esser L; Xia D
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2009 Nov; 65(Pt 11):1166-70. PubMed ID: 19923742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inclusion body myopathy, Paget's disease of the bone and fronto-temporal dementia: a disorder of autophagy.
    Ju JS; Weihl CC
    Hum Mol Genet; 2010 Apr; 19(R1):R38-45. PubMed ID: 20410287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inclusion body myopathy-associated mutations in p97/VCP impair endoplasmic reticulum-associated degradation.
    Weihl CC; Dalal S; Pestronk A; Hanson PI
    Hum Mol Genet; 2006 Jan; 15(2):189-99. PubMed ID: 16321991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific inhibition of p97/VCP ATPase and kinetic analysis demonstrate interaction between D1 and D2 ATPase domains.
    Chou TF; Bulfer SL; Weihl CC; Li K; Lis LG; Walters MA; Schoenen FJ; Lin HJ; Deshaies RJ; Arkin MR
    J Mol Biol; 2014 Jul; 426(15):2886-99. PubMed ID: 24878061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.